The latest articles from BioStock
» Odinwell's CEO on the listing plans and the company's smart wound products
» Fluicell invests in regenerative medicine
» Cyxone in collaboration with leading expert in rheumatoid arthritis
» Iconovo's CEO on the extended agreement with Amneal
» BiBBInstruments remains optimistic despite temporary pause in studies
Read BioStock's newsletter for week 19 here.
BioStock Life Science Summit with presentations by over 25 highly relevant companies and several panel discussions will be held on May 26th – 27th. Read more.
has entered into an agreement with Gazel Energy Generation for a production facility of CyreneTM. Read more.
Asarina Pharma has received approval on CTA for a phase IIa study regarding Tourette syndrome. Read more.
sectra will install its digital pathology solution at Institute Cure. Read more.
Janssen announces that NT Council has published an updated recommendation and balanced assessment to the regions regarding treatment with Darzalex in multiple myeloma. Read more.
ZICCUM have signaled that they welcome the calls aimed at reducing inequalities in vaccine access and preventing future pandemics. Read more.
Nanexa has been granted a patent in China. Read more.
NeoDynamics has presented its quarterly report from Q1 2021. Read more.
NattoPharma has reported on the results of the offering of outstanding shares. Read more.
Allarity Therapeutics has announced that they have decided to carry out a new share issue with preferential rights for the company's existing shareholders. Read more.
ExpreS2ion Biotechnologies has reported its financial results for Q1 2021. Read more.
Vistin Pharma has reported on transactions carried out by senior executives. Read more.
Targovax has reported on transactions carried out by senior executives. Read more.
Reports:
Alzinova BergenBio BergenBio Cereno Scientific Enorama Pharma Glycorex Transplant Inhalation Sciences Sweden Lipigon Pharmaceuticals Photocure SpectraCure
Communiqués:
Alzinova Calmark Sweden Iconovo Moberg Pharma SpectraCure
Notices of general meetings:
AroCell Brighter Curasight Follicum
News received since yesterday lunch:
Xintela has announced that the company's stem cell product XSTEM can regenerate cartilage in a preclinical animal model. Read more.
Chordate Medical has informed that the company's patient study on chronic migraine is also being resumed in Germany. Read more.
PEPTONIC Medical has presented the nomination committee's proposal ahead of the 2021 Annual General Meeting. Read more.
Pharmacologist has launched a new software version for WasteLog and DrugLog. Read more.
DBP International Rights issue has been oversubscribed – eight out of ten milestones for the clinical trial of SI-053 has been completed. Read more.
The board of directors Isofol has decided on a fully guaranteed rights issue of approximately SEK 400 million. Read more.
Per Aniansson has been appointed as a new member of Attanas board. Read more.
NattoPharma has informed about changes in shareholdings. Read moreThe company has also announced that it does not intend to extend the offer period for the purchase of remaining shares. Read more.
Targovax has decided to increase the share capital following the exercise of RSUs. Read more.
The Annual General Meeting was held in SciBase. Read more.
Record date for split of shares in Sedana Medical has been set for May 27, 2021. Read more.
Prostatype Genomics has called an annual general meeting and a virtual information meeting. Read more.
ArcticZymes Technologies has reported on transactions carried out by senior executives. Read more.
Enorama Pharma has postponed the Annual General Meeting until June 23, 2021. Read more.
EXACT Therapeutics AS has presented its annual report for 2020. Read more.
This morning's winner: Nordic Nanovector +8,6%, SensoDetect +7,4%, Alphahelix +6,4%, ODI Pharma +6,2%, SenzaGen +5,7%, Herantis Pharma +5,0%
This morning's losers: QuiaPEG -10,8%, Allarity Therapeutics -9,7%, BiBBInstruments -8,7%, Cereno Scientific -7,4%, AroCell -7,4%, Micropos Medical -7,2%
Index: OMXS30 2208,55 -1,83%, Healthcare -0,10%
More articles from BioStock
» Chordate Medical's CEO on CE marking in chronic migraine
» BioStock Studio: Idogen's CEO on the Q1 report
» 2cureX unlocks the power of precision oncology
» New CEO for Xintela's subsidiary Targinta
» Covid unmasks need for better mental health medication